- Home
- TMDX vs AGYS Comparison
TMDX vs AGYS Comparison
Compare TMDX & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- AGYS
- Stock Information
- Founded
- TMDX 1998
- AGYS 1963
- Country
- TMDX United States
- AGYS United States
- Employees
- TMDX N/A
- AGYS N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AGYS EDP Services
- Sector
- TMDX Health Care
- AGYS Technology
- Exchange
- TMDX Nasdaq
- AGYS Nasdaq
- Market Cap
- TMDX 2.4B
- AGYS 2.4B
- IPO Year
- TMDX 2019
- AGYS N/A
- Fundamental
- Price
- TMDX $71.95
- AGYS $77.54
- Analyst Decision
- TMDX Buy
- AGYS Strong Buy
- Analyst Count
- TMDX 11
- AGYS 5
- Target Price
- TMDX $116.10
- AGYS $138.00
- AVG Volume (30 Days)
- TMDX 1.3M
- AGYS 417.0K
- Earning Date
- TMDX 02-27-2025
- AGYS 01-21-2025
- Dividend Yield
- TMDX N/A
- AGYS N/A
- EPS Growth
- TMDX N/A
- AGYS N/A
- EPS
- TMDX 0.94
- AGYS 0.79
- Revenue
- TMDX $401,090,000.00
- AGYS $263,572,999.00
- Revenue This Year
- TMDX $81.61
- AGYS $17.25
- Revenue Next Year
- TMDX $22.52
- AGYS $20.76
- P/E Ratio
- TMDX $76.78
- AGYS $98.15
- Revenue Growth
- TMDX 109.09
- AGYS 15.53
- 52 Week Low
- TMDX $55.00
- AGYS $74.03
- 52 Week High
- TMDX $177.37
- AGYS $142.64
- Technical
- Relative Strength Index (RSI)
- TMDX 52.52
- AGYS 25.84
- Support Level
- TMDX $66.81
- AGYS $81.84
- Resistance Level
- TMDX $80.00
- AGYS $88.89
- Average True Range (ATR)
- TMDX 4.14
- AGYS 3.43
- MACD
- TMDX 0.57
- AGYS 0.65
- Stochastic Oscillator
- TMDX 48.74
- AGYS 0.00
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About AGYS Agilysys Inc.
Agilysys Inc has been a leader in hospitality software, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate food service management, restaurants, universities, stadiums, and healthcare. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service.